Colla corii asini might upregulate ZNF471 and THOC5 by KRAB domain–containing zinc-finger protein pathway and THO complex subunit 5 pathway to improve anemia of pregnant women with β-thalassemia
Pregnant patients with β-thalassemia are more likely to have progressive anemia which expose them to risk of adverse pregnancy outcomes, blood transfusion, and iron overload. Results from our previous study indicated that Colla corii asini (CCA, E’jiao), a natural ingredient of traditional Chinese medicine, could significantly increase hemoglobin level of pregnant women with β- thalassemia, but the underlying molecular mechanism was unclear. Thus, we applied high-throughput transcriptome sequencing to study the transcriptomic change before and after the CCA treatment. Twenty eligible pregnant women were recruited and randomized to either the CCA treatment group or the blank control group in a 3:1 ratio. Patients in the treatment group orally received daily 15 g CCA powder for 4 weeks. We analyzed the therapeutic effect indexes and the transcriptomic change in subjects’ peripheral blood before and after treatment. We found that β CD 41-42(-TTCT)/βA was the main genotype of the subjects. The regulatory impact of CCA treatment became more evident among the subjects of genotype β CD 41-42(-TTCT)/βA. Gene ontogenesis analysis revealed that the top five molecular functions of differentially expressed genes were involved in membrane functionality and cellular structure. We further identified two consistent upregulated genes ZNF471 and THOC5 in the effective treatment group, which were engaged in Kruppel-associated box (KRAB) domain-containing zinc-finger protein pathway and THOC5 pathway, respectively. Based on our current findings, we hypothesize that the anti-anemia effect of CCA on pregnant women with β-thalassemia might be related to translation regulation of spectrin synthesis, membrane stability, and eventually prolonged the life span of erythrocytes.
Keywordsβ-thalassemia Anemia Pregnancy Transcriptome sequencing Colla corii asini
This study was supported by the Science and Technology Project of Guangdong Province (grant no. 2017ZC0150) and by grants from the National Natural Science Foundation of China (grant no. 81704111).
Compliance with ethical standards
The procedures performed in the study were approved by the local ethics committee and were conducted in accordance with the current version of the Declaration of Helsinki.
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Yin A, Li B, Luo M, Xu L, Wu L, Zhang L, Ma Y, Chen T, Gao S, Liang J, Guo H, Qin D, Wang J, Yuan T, Wang Y, Huang WW, He WF, Zhang Y, Liu C, Xia S, Chen Q, Zhao Q, Zhang X (2014) The prevalence and molecular spectrum of alpha- and beta-globin gene mutations in 14,332 families of Guangdong Province, China. PLoS One 9(2):e89855CrossRefGoogle Scholar
- 2.Rakhi PN, Sophie L (2012) Baby on board: what you need to know about pregnancy in the hemoglobinopathies. Hematology 208–213Google Scholar
- 5.Amooee S, Samsami A, Jahanbakhsh J (2011) The pregnancy outcome in patients with minor β-thalassemia. Iran J Reprod Med 9(1):9–14Google Scholar
- 8.Cappellini MD, Cohen A, Eleftheriou A et al (2008) Guidelines for the clinical management of thalassaemia. Thalassaemia International Federation, NicosiaGoogle Scholar
- 9.Benoist BD, Mclean E, Egli I et al (2008) Worldwide prevalence of anaemia 1993–2005; WHO global database on anaemia. World Health Organization, GenevaGoogle Scholar
- 13.Muncie HJ, Campbell J (2009) Alpha and beta thalassemia. Am Fam Physician 80:339–344Google Scholar
- 14.Lichtman MA, Kipps TJ, Seligsohn U et al Williams hematology, 8th edn. http://www.accessmedicine.com. Accessed 12 May 2019